Biotech / PharmaPhoenix / Scottsdale
Siamab Therapeutics
Biotech / Pharma
, AZ
Siamab Therapeutics is a biopharmaceutical company developing novel cancer therapeutics that target cancer-specific carbohydrate antigens (glycans) expressed on cancer cells. The company focuses on antibody-based therapies directed at abnormal carbohydrate structures unique to tumor cells. In 2019, Siamab completed a $202 million exit, notable for being angel-funded throughout its development.
Founded
Region
Phoenix / Scottsdale
Investors
People